Baird Financial Group
IMMU

Baird Financial Group’s Immunomedics Inc IMMU Stock Holding History

Baird Financial Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,240
Closed -$275K – 1624
2020
Q3 		$275K Buy
+3,240
New +$164K ﹤0.01% 1324

Baird Financial Group's IMMU Position: Q4 2020 in Review

Baird Financial Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 3,240 shares — an estimated $275K sold.

Baird Financial Group first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $275K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Baird Financial Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Baird Financial Group sold 3,240 Immunomedics Inc shares in Q4 2020, an estimated $275K.
  • Baird Financial Group first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Baird Financial Group's Immunomedics Inc position peaked at $275K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Baird Financial Group's 13F filing for Q4 2020, filed 11 Feb 2021.